Acadia Pharmaceuticals Inc

ACAD 
(NASDAQ) 
 
$ 17.69 <%= Resources.Global.txtUp %>
Updated 25/05/2018
Change % 1.26% Stock price increasing
Change 0.22 Stock price increasing
Volume 296,216
High $ 17.83
Low $ 17.30
Open $ 17.42
ISIN
Prev close $ 17.47
# of shares 124.83M
Market cap 2,208.17M USD
Intraday

Market closed
Acadia Pharmaceuticals Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  17.69 -1.7% Stock price decreasing 8.7% Stock price increasing -43.2% Stock price decreasing -35.9% Stock price decreasing -32.0% Stock price decreasing
Powered by TradingView

Company profile

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
27 May 2018 00:10:57
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180525.2 - EUROWEB2 - 2018-05-27 01:10:57 - 2018-05-27 00:10:57 - 1000 - Website: OKAY